NAVAL AIR STATION SIGONELLA, Italy – In May, Naval Medical Research Unit (NAMRU) EURAFCENT entered into two cooperative research and development agreements (CRADAs) with Seek Laboratories, Inc.
These collaborations focus on advancing field-deployable diagnostic and therapeutic countermeasures that support force health protection and warfighter readiness.
Under a four-year agreement, NAMRU EURAFCENT will employ Seek Labs’ diagnostic and therapeutic platforms in operational environments, leveraging its expertise in clinical research and biosurveillance to deliver field-ready capabilities.
“This collaboration is a clear example of how we are actively working to deliver scalable, field-ready solutions for the fleet and joint...
NAVAL AIR STATION SIGONELLA, Italy (July 21, 2026) Components of the SeekIt field kit, designed for use in forward and resource-limited environments. Researchers at Naval Medical Research Unit (NAMRU) EURAFCENT will evaluate the kit's operational capabilities to ensure it meets the rigorous diagnostic demands of military deployments. The kit is intended to provide full laboratory-grade molecular test, to include extraction, amplification and detection, into a portable pouch for use by deployed medical teams, in expeditionary operations, for shipboard use and outbreak surveillance in austere environments. NAMRU EURAFCENT, part of Navy Medicine Research & Development, conducts research, surveillance and studies of vaccines, therapeutic agents, diagnostic assays and vector control measures in the EUCOM, AFRICOM and CENTCOM Areas of Responsibility to better prevent and treat infectious diseases in support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality. (Courtesy Photo/Released)
